| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000025134 |
| Receipt No. | R000028905 |
| Official scientific title of the study | Multicenter Randomized Controlled Trial for the usefulness of Dual Red Imaging in endoscopic submucosal dissection |
| Date of disclosure of the study information | 2016/12/04 |
| Last modified on | 2017/12/19 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Multicenter Randomized Controlled Trial for the usefulness of Dual Red Imaging in endoscopic submucosal dissection | |
| Title of the study (Brief title) | DRI | |
| Region |
|
|
| Condition | ||
| Condition | early esophageal cancer, early gastric cancer, colorectal adenoma, early colorectal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We evaluated the efficacy of DRI that facilitate for hemostasis management and shorten the treatment timeshortness in patients undergoing ESD. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Shortening the time required for hemostasis. |
| Key secondary outcomes | Shortening the treatment time
Perforation rate |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The endoscopist commenced the ESD using WLI, switched to DRI immediately when bleeding was detected, then switched back to WLI upon obtaining hemostasis (DRI group). | |
| Interventions/Control_2 | The endoscopist underwent ESD using WLI throughout the entire intervention. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Early esophageal cancer, depth of cancer invasion is EP or LPM.
2.Early gastric cancer, depth of cancer invasion is mucosal layer or submucosal layer1. 3.Colorectal adenoma, en bloc resection is difficult. 4.Early colorectal cancer, depth of cancer invasion is M or SM1. 5.There is no previous treatment for organ to treat. 6.Blood examination Hemoglobin more than 8.0g/dL, platelet less than 100000 /mm3. 7.Age more than 20,less than 80 years old 8.PS, 0 or 1. 9. We get informed consent from a patient. |
|||
| Key exclusion criteria | 1.More than two lesion are going to be treated.
2.A patient with the bleeding tendency. 3.During dialysis. 4.Residual and reccurence lesion. |
|||
| Target sample size | 400 | |||
| Research contact person | |
| Name of lead principal investigator | Naohisa Yahagi |
| Organization | Keio University School of Medicine |
| Division name | Division of Research and Development for Minimally Invasive Treatment, Cancer Center |
| Address | 35 Shinanomachi, Shinjyuku-ku, Tokyo, Japan. 160-8582 |
| TEL | 03-5363-3437 |
| yahagi.keio@gmail.com | |
| Public contact | |
| Name of contact person | Ai Fujimoto |
| Organization | Keio University School of Medicine |
| Division name | Division of Research and Development for Minimally Invasive Treatment, Cancer Center |
| Address | 35 Shinanomachi, Shinjyuku-ku, Tokyo, Japan. 160-8582 |
| TEL | 03-5363-3437 |
| Homepage URL | |
| ai-fujimoto@a8.keio.jp | |
| Sponsor | |
| Institute | Keio University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Keio University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028905 |